Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey D Barnes

Showing results (221-230 of 290) with videos related to

Pageof 29
Sort By:
Journal of Thrombosis and Thrombolysis|July 17, 2012
Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)Geoffrey D Barnes, Scott Kaatz, Vlad Golgotiu, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 30, 2022
Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among AdultsJana L Hirschtick, Steven Cook, Akash Patel, et al.
Journal of Thrombosis and Thrombolysis|November 13, 2016
Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulantZachary D Hale, Xiowen Kong, Brian Haymart, et al.
Vascular Medicine (London, England)|March 1, 2019
Missed opportunities to prevent upper GI hemorrhage: The experience of the Michigan Anticoagulation Quality Improvement InitiativeJacob E Kurlander, Xiaokui Gu, James M Scheiman, et al.
Journal of Thrombosis and Thrombolysis|February 10, 2018
Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulationJacob E Kurlander, Geoffrey D Barnes, Michelle A Anderson, et al.
JACC. Advances|April 26, 2025
A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous ThromboembolismJordan K Schaefer, Josh Errickson, Xiaowen Kong, et al.
The American Journal of Managed Care|September 17, 2021
Diagnostic patterns and stress testing trends after implementing high-sensitivity troponin assayRaymond Y Yeow, Henry Han, James Henderson, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2024
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolismCristina Gabara, Jesus Aibar, Yuji Nishimoto, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2020
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
Contemporary Clinical Trials|December 7, 2024
Evaluation of patient and encounter decision aid interventions for atrial fibrillation: Baseline characteristics of the RED-AF study - A Randomized Controlled TrialTanvi Nayak, Joshua T Christensen, Tyler Bardsley, et al.
Pageof 29

Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
Journal of Thrombosis and Thrombolysis|July 17, 2012
Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)Geoffrey D Barnes, Scott Kaatz, Vlad Golgotiu, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 30, 2022
Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among AdultsJana L Hirschtick, Steven Cook, Akash Patel, et al.
Journal of Thrombosis and Thrombolysis|November 13, 2016
Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulantZachary D Hale, Xiowen Kong, Brian Haymart, et al.
Vascular Medicine (London, England)|March 1, 2019
Missed opportunities to prevent upper GI hemorrhage: The experience of the Michigan Anticoagulation Quality Improvement InitiativeJacob E Kurlander, Xiaokui Gu, James M Scheiman, et al.
Journal of Thrombosis and Thrombolysis|February 10, 2018
Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulationJacob E Kurlander, Geoffrey D Barnes, Michelle A Anderson, et al.
JACC. Advances|April 26, 2025
A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous ThromboembolismJordan K Schaefer, Josh Errickson, Xiaowen Kong, et al.
The American Journal of Managed Care|September 17, 2021
Diagnostic patterns and stress testing trends after implementing high-sensitivity troponin assayRaymond Y Yeow, Henry Han, James Henderson, et al.
Journal of Thrombosis and Haemostasis : JTH|May 18, 2024
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolismCristina Gabara, Jesus Aibar, Yuji Nishimoto, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2020
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
Contemporary Clinical Trials|December 7, 2024
Evaluation of patient and encounter decision aid interventions for atrial fibrillation: Baseline characteristics of the RED-AF study - A Randomized Controlled TrialTanvi Nayak, Joshua T Christensen, Tyler Bardsley, et al.
Pageof 29